STOCK MARKET BSE NSE

Chemo Pharma to invest Rs 100 crore, expand ops in TS

Spain-headquartered Chemo Pharma has announced investment of over `100 crore for creation of its second-line production of pharmaceutical dosage forms in Hyderabad.

Published: 24th May 2022 04:47 AM  |   Last Updated: 24th May 2022 04:47 AM   |  A+A-

pills, medicines

Image used for representational purpose only. (Express Illustrations)

By Express News Service

HYDERABAD: Spain-headquartered Chemo Pharma has announced investment of over `100 crore for creation of its second-line production of pharmaceutical dosage forms in Hyderabad. In 2021, the company established additional QC and Stability Labs in its facility in Hyderabad and is now gearing up to commence commercial operations utilising the second line production.

The company also plans to initiate a new Active Pharmaceutical Ingredient and R&D Centre in Hyderabad along with continuing new product development activities in solids and injectables in Genome Valley.
The announcement was made after IT & Industries Minister KT Rama Rao met Jean Daniel Bonny, Chemo Group R&D director - Pharmaceuticals Generics Business at the World Economic Forum, Davos. 

Chemo India Formulation started its operations in Genome Valley, Hyderabad in 2018 with research, development and manufacturing of pharmaceutical finished dosage forms with specialisation in oral dosage formulations. Since then, the company has witnessed tremendous growth and invested around `170 crore till now while creating employment for 270 people.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp